FMED | IBB | FMED / IBB | |
Gain YTD | -2.597 | -1.584 | 164% |
Net Assets | 53.4M | 5.47B | 1% |
Total Expense Ratio | 0.50 | 0.45 | 111% |
Turnover | 33.00 | 22.00 | 150% |
Yield | 0.47 | 0.30 | 154% |
Fund Existence | 5 years | 24 years | - |
FMED | IBB | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago75% | 4 days ago90% |
Momentum ODDS (%) | 4 days ago86% | 4 days ago85% |
MACD ODDS (%) | 4 days ago79% | 4 days ago85% |
TrendWeek ODDS (%) | 4 days ago79% | 4 days ago84% |
TrendMonth ODDS (%) | 4 days ago82% | 4 days ago85% |
Advances ODDS (%) | 7 days ago81% | 4 days ago86% |
Declines ODDS (%) | 5 days ago79% | 20 days ago85% |
BollingerBands ODDS (%) | 4 days ago79% | 4 days ago86% |
Aroon ODDS (%) | 4 days ago81% | 4 days ago84% |
A.I.dvisor indicates that over the last year, FMED has been closely correlated with DHR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if FMED jumps, then DHR could also see price increases.
Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
---|---|---|---|---|
FMED | 100% | +0.32% | ||
DHR - FMED | 68% Closely correlated | +0.35% | ||
ISRG - FMED | 67% Closely correlated | +0.72% | ||
TECH - FMED | 66% Closely correlated | -0.08% | ||
RGEN - FMED | 65% Loosely correlated | +0.40% | ||
TMO - FMED | 64% Loosely correlated | +0.37% | ||
More |
A.I.dvisor indicates that over the last year, IBB has been closely correlated with KRYS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBB jumps, then KRYS could also see price increases.
Ticker / NAME | Correlation To IBB | 1D Price Change % | ||
---|---|---|---|---|
IBB | 100% | +0.35% | ||
KRYS - IBB | 69% Closely correlated | +1.22% | ||
DNLI - IBB | 68% Closely correlated | -1.41% | ||
IQV - IBB | 67% Closely correlated | -0.25% | ||
IDYA - IBB | 67% Closely correlated | +0.82% | ||
ROIV - IBB | 66% Loosely correlated | +0.18% | ||
More |